IP Library Granted Patent US 12,527,490
Granted Patent B2
US 12,527,490 · App. 16/092,872 · Granted Jan 20, 2026

Medical device making treatment recommendations based on sensed characteristics of a lesion

Inventors: Franz Bozsak (Versailles, FR); Bruno Carreel (Paris, FR); Pierluca Messina (Paris, FR); Myline Cottance (Paris, FR)
Assignee: Sensome SAS
A61B5/0538A61B5/0036A61B18/1477G16B40/20A61B5/02007A61B5/0536A61B2018/00577A61B2034/252G16H20/40G16H50/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,527,490
App. No.
16/092,872
Granted
Jan 20, 2026
Kind
B2
Abstract

Embodiments described relate to a medical device including an invasive probe that, when inserted into an animal (e.g., a human or non-human animal, including a human or non-human mammal), may aid in diagnosing and/or treating a lesion of the animal (e.g., a growth or deposit within vasculature that fully or partially blocks the vasculature). The invasive probe may have one or more sensors to sense characteristics of the lesion, including by detecting one or more characteristics of tissues and/or biological materials of the lesion. The medical device may be configured to analyze the characteristics of a lesion and, based on the analysis, provide treatment recommendations to a clinician. Such treatment recommendations may include a manner in which to treat a lesion, such as which treatment to use to treat a lesion and/or a manner in which to use a treatment device.

Claims (37)

1 . A method of operating a medical device for diagnosis and/or treatment of a lesion of an animal, the medical device comprising an invasive probe to be inserted into the animal and removed from the animal following diagnosis and/or treatment of the lesion, the method comprising:

generating, with the invasive probe of the medical device while the invasive probe is disposed within the animal, an impedance measurement of a plurality of biological materials of the lesion measured by the invasive probe at a plurality of locations of the lesion, wherein generating the impedance measurement comprises operating the invasive probe to apply an electrical signal at a plurality of frequencies and operating a plurality of sensors of the invasive probe to measure impedance of the plurality of biological materials of the lesion;

selecting, using at least one processor of the medical device, from among a plurality of other medical devices that may be used to treat lesions and based at least in part on an evaluation of the impedance measurement of the plurality of biological materials of the lesion, at least one of the plurality of other medical devices to recommend for treatment of the lesion, wherein the invasive probe of the medical device and each of the plurality of other medical devices are configured for separate insertion into the animal; and

outputting the at least one of the plurality of other medical devices for presentation to a user via a user interface.

2 . The method of claim 1 , wherein:

the lesion is a lesion of a duct of the animal, and the duct of the animal is vasculature of the animal; and

generating the impedance measurement while the invasive probe is disposed within the animal comprises generating the impedance measurement while the invasive probe is disposed within the vasculature of the animal.

3 . The method of claim 1 , wherein operating the plurality of sensors of the invasive probe to measure the impedance of the lesion comprises operating the plurality of sensors to measure, with each sensor, an impedance spectrum of a biological material, of the plurality of biological materials of the lesion, contacting the sensor.

4 . The method of claim 3 , further comprising:

identifying, based on the impedance measurement at the plurality of locations, the plurality of biological materials present in the lesion.

5 . The method of claim 4 , further comprising:

identifying the lesion, wherein identifying the lesion comprises identifying the lesion based at least in part on the plurality of biological materials present in the lesion.

6 . The method of claim 5 , wherein selecting the at least one of the plurality of other medical devices to recommend for treatment of the lesion comprises selecting the at least one of the plurality of other medical devices based at least in part on an identity of the lesion and/or on the plurality of biological materials present in the lesion.

7 . The method of claim 1 , wherein selecting the at least one of the plurality of other medical devices to recommend for treatment of the lesion based on the evaluation of the impedance measurement of the plurality of biological materials of the lesion comprises:

comparing the impedance measurement to one or more conditions associated with each of the plurality of other medical devices, the plurality of other medical devices each being associated with a different one or more conditions; and

in response to determining that the impedance measurement satisfies the one or more conditions associated with a medical device of the plurality of other medical devices, selecting the medical device of the plurality of other medical devices as the at least one of the plurality of other medical devices to recommend for treatment of the lesion.

8 . The method of claim 1 , wherein the plurality of other medical devices comprises:

at least one ablative medical device; and

at least one non-ablative medical device.

9 . The method of claim 1 , wherein the plurality of other medical devices comprises a stent-retriever.

10 . The method of claim 1 , wherein the plurality of other medical devices comprises an aspiration catheter.

11 . The method of claim 1 , wherein the plurality of other medical devices comprises a stent.

12 . The method of claim 1 , further comprising:

transmitting measurement data from the plurality of sensors to a measurement circuit of the invasive probe, wherein the measurement circuit is disposed within vasculature of the animal; and

identifying, with the measurement circuit disposed within the vasculature of the animal, the biological materials of the lesion.

13 . At least one non-transitory computer-readable storage medium having encoded thereon executable instructions that, when executed by at least one processor, cause the at least one processor to carry out a method of operating a medical device for diagnosis and/or treatment of a lesion of an animal, the medical device comprising an invasive probe to be inserted into the animal and removed from the animal following diagnosis and/or treatment of the lesion, the method comprising:

generating, with the invasive probe of the medical device while the invasive probe is disposed within the animal, an impedance measurement of a plurality of biological materials of the lesion measured by the invasive probe at a plurality of locations of the lesion, wherein generating the impedance measurement comprises operating the invasive probe to apply an electrical signal at a plurality of frequencies and operating a plurality of sensors of the invasive probe to measure impedance of the plurality of biological materials of the lesion;

selecting, using at least one processor of the medical device, from among a plurality of other medical devices that may be used to treat lesions and based at least in part on an evaluation of the impedance measurement of the plurality of biological materials of the lesion, at least one of the plurality of other medical devices to recommend for treatment of the lesion, wherein selecting the at least one of the plurality of other medical devices to recommend for treatment of the lesion comprises:

comparing the impedance measurement to one or more conditions associated with each of the plurality of other medical devices, the plurality of other medical devices each being associated with a different one or more conditions; and

in response to determining that the impedance measurement satisfies the one or more conditions associated with a medical device of the plurality of other medical devices, selecting the medical device of the plurality of other medical devices as the at least one of the plurality of other medical devices to recommend for treatment of the lesion; and

outputting the at least one of the plurality of other medical devices for presentation to a user via a user interface.

14 . An apparatus comprising:

at least one processor; and

at least one non-transitory computer-readable storage medium having encoded thereon executable instructions that, when executed by the at least one processor, cause the at least one processor to carry out a method of operating a medical device for diagnosis and/or treatment of a lesion of an animal, the medical device comprising an invasive probe to be inserted into the animal and removed from the animal following diagnosis and/or treatment of the lesion, the method comprising:

generating, with the invasive probe of the medical device while the invasive probe is disposed within the animal, an impedance measurement of a plurality of biological materials of the lesion measured by the invasive probe at a plurality of locations of the lesion, wherein generating the impedance measurement comprises operating the invasive probe to apply an electrical signal at a plurality of frequencies and operating a plurality of sensors of the invasive probe to measure impedance of the plurality of biological materials of the lesion;

selecting, using at least one processor of the medical device, from among a plurality of other medical devices that may be used to treat lesions and based at least in part on an evaluation of the impedance measurement of the plurality of biological materials of the lesion, at least one of the plurality of other medical devices to recommend for treatment of the lesion, wherein the invasive probe of the medical device and each of the plurality of other medical devices are configured for separate insertion into the animal; and

outputting the at least one of the plurality of other medical devices for presentation to a user via a user interface.

Assignments (13)
CORRECTIVE ASSIGNMENT TO CORRECT THE FIRST CONVEYING PARTY NAME PREVIOUSLY RECORDED ON REEL 053299 FRAME 0625. ASSIGNOR(S) HEREBY CONFIRMS THE CONVEYING PARTY NAME FRANK BOZSAK SHOULD BE FRANZ BOZSAK. Recorded Sep 4, 2020
From: BOZSAK, FRANZ; CARREEL, BRUNO; MESSINA, PIERLUCA; COTTANCE, MYLINE
To: INSTENT SAS
Reel/Frame 053704/0296 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CORRESPONDENCE ADDRESS PREVIOUSLY RECORDED AT REEL: 053306 FRAME: 0069. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Sep 4, 2020
From: ÉCOLE POLYTECHNIQUE
To: INSTENT SAS
Reel/Frame 053704/0940 →
CORRECTIVE ASSIGNMENT TO CORRECT THE UPLOADED ASSIGNMENT DOCUMENT PREVIOUSLY RECORDED ON REEL 053303 FRAME 0283. ASSIGNOR(S) HEREBY CONFIRMS THE PREVIOUSLY UPLOADED ASSIGNMENT DOCUMENT SHOULD BE REPLACED WITH THE NEWLY UPLOADED NAME CHANGE DOCUMENT. Recorded Sep 4, 2020
From: INSTENT SAS
To: SENSOME SAS
Reel/Frame 054157/0619 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 24, 2020
From: BOZSAK, FRANZ
To: SENSOME SAS
Reel/Frame 053303/0231 →
CHANGE OF NAME Recorded Jul 24, 2020
From: INSTENT SAS
To: SENSOME SAS
Reel/Frame 053303/0283 →
CONFIRMATORY ASSIGNMENT Recorded Jul 24, 2020
From: ÉCOLE POLYTECHNIQUE
To: INSTENT SAS
Reel/Frame 053306/0069 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 24, 2020
From: BOZSAK, FRANK; CARREEL, BRUNO; MESSINA, PIERLUCA; COTTANCE, MYLINE
To: INSTENT SAS
Reel/Frame 053299/0625 →
CONFIRMATORY ASSIGNMENT Recorded Jul 24, 2020
From: CARREEL, BRUNO
To: INSTENT SAS
Reel/Frame 053306/0094 →
CONFIRMATORY ASSIGNMENT Recorded Jul 24, 2020
From: COTTANCE, MYLINE
To: INSTENT SAS
Reel/Frame 053307/0200 →
CONFIRMATORY ASSIGNMENT Recorded Jul 24, 2020
From: MESSINA, PIERLUCA
To: INSTENT SAS
Reel/Frame 053310/0583 →
CONFIRMATORY ASSIGNMENT Recorded Jul 24, 2020
From: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
To: INSTENT SAS
Reel/Frame 053306/0087 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 24, 2020
From: INSTENT SAS
To: ÉCOLE POLYTECHNIQUE
Reel/Frame 053301/0771 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 24, 2020
From: INSTENT SAS
To: LE CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
Reel/Frame 053301/0796 →
Continuity (2)
Provisional Application 62321001 · Apr 11, 2016
Related Publication 20190388002A1 · Dec 26, 2019
References Cited (150)
US 5447529A · Marchlinksi et al. · 1995 [cited by applicant]
US 5800350A · Coppleson et al. · 1998 [cited by applicant]
US 5938624A · Akerfeldt et al. · 1999 [cited by applicant]
US 6063028A · Luciano · 2000 [cited by applicant]
US 6090052A · Akerfeldt et al. · 2000 [cited by applicant]
US 6106486A · Tenerz et al. · 2000 [cited by applicant]
US 6112598A · Tenerz et al. · 2000 [cited by applicant]
US 6206835B1 · Spillman, Jr. et al. · 2001 [cited by applicant]
US 6428336B1 · Akerfeldt · 2002 [cited by applicant]
US 6437551B1 · Krulevitch et al. · 2002 [cited by applicant]
US 6461301B2 · Smith · 2002 [cited by applicant]
US 6679269B2 · Swanson · 2004 [cited by applicant]
US 8277386B2 · Ahmed et al. · 2012 [cited by applicant]
US 8491567B2 · Magnin et al. · 2013 [cited by applicant]
US 8777898B2 · Suon et al. · 2014 [cited by applicant]
US 8840560B2 · Hossack et al. · 2014 [cited by applicant]
US 9121806B1 · Bhansali et al. · 2015 [cited by applicant]
US 9301699B2 · Hubinette et al. · 2016 [cited by applicant]
US 10912482B2 · Bozsak et al. · 2021 [cited by applicant]
US 20010051774A1 · Littrup et al. · 2001 [cited by applicant]
US 20020043113A1 · Tulkki et al. · 2002 [cited by applicant]
US 20020077627A1 · Johnson et al. · 2002 [cited by applicant]
US 20020177782A1 · Penner · 2002 [cited by applicant]
US 20030120328A1 · Jenkins · 2003 [cited by examiner]
US 20050065592A1 · Holzer · 2005 [cited by applicant]
US 20060047205A1 · Ludomirsky et al. · 2006 [cited by applicant]
US 20060254600A1 · Danek et al. · 2006 [cited by applicant]
US 20070255145A1 · Smith et al. · 2007 [cited by applicant]
US 20070255270A1 · Carney · 2007 [cited by applicant]
US 20080262489A1 · Steinke · 2008 [cited by applicant]
US 20090137908A1 · Patwardhan · 2009 [cited by examiner]
US 20100191141A1 · Aberg · 2010 [cited by applicant]
US 20100222647A1 · Hashimshony et al. · 2010 [cited by applicant]
US 20110054583A1 · Litt et al. · 2011 [cited by applicant]
US 20110251469A1 · Varadan · 2011 [cited by applicant]
US 20120016206A1 · Ramarajan et al. · 2012 [cited by applicant]
US 20120036689A1 · Sjosten et al. · 2012 [cited by applicant]
US 20120061257A1 · Yu et al. · 2012 [cited by applicant]
US 20120172731A1 · Smith · 2012 [cited by applicant]
US 20120190989A1 · Kaiser et al. · 2012 [cited by applicant]
US 20120316454A1 · Carter · 2012 [cited by applicant]
US 20120323232A1 · Wolf · 2012 [cited by examiner]
US 20130197357A1 · Green · 2013 [cited by examiner]
US 20130274712A1 · Schecter · 2013 [cited by applicant]
US 20130282084A1 · Mathur et al. · 2013 [cited by applicant]
US 20140005558A1 · Gregorich · 2014 [cited by applicant]
US 20140058197A1 · Salahieh et al. · 2014 [cited by applicant]
US 20140058275A1 · Gregorich et al. · 2014 [cited by applicant]
US 20140066790A1 · Burkett et al. · 2014 [cited by applicant]
US 20140066791A1 · Burkett · 2014 [cited by applicant]
US 20140081244A1 · Voeller et al. · 2014 [cited by applicant]
US 20140180031A1 · Anderson · 2014 [cited by applicant]
US 20140276109A1 · Gregorich · 2014 [cited by applicant]
US 20140276223A1 · Gustafsson · 2014 [cited by applicant]
US 20140284422A1 · Sapir · 2014 [cited by applicant]
US 20140343382A1 · Kersey et al. · 2014 [cited by applicant]
US 20150032011A1 · McGowan et al. · 2015 [cited by applicant]
US 20150051499A1 · McGowan · 2015 [cited by applicant]
US 20150157273A1 · An et al. · 2015 [cited by applicant]
US 20150209526A1 · Matsubara et al. · 2015 [cited by applicant]
US 20150297807A1 · Leblanc et al. · 2015 [cited by applicant]
US 20150313478A1 · Veszelei et al. · 2015 [cited by applicant]
US 20160051323A1 · Stigall et al. · 2016 [cited by applicant]
US 20160058382A1 · Burkett et al. · 2016 [cited by applicant]
US 20160058977A1 · Burkett et al. · 2016 [cited by applicant]
US 20160073957A1 · Szunyog · 2016 [cited by applicant]
US 20160121085A1 · Burkett et al. · 2016 [cited by applicant]
US 20160157787A1 · Merritt · 2016 [cited by examiner]
US 20160220302A1 · Zarins · 2016 [cited by examiner]
US 20160287178A1 · Ranganathan et al. · 2016 [cited by applicant]
US 20160303354A1 · Burkett et al. · 2016 [cited by applicant]
US 20160335413A1 · Davidson · 2016 [cited by examiner]
US 20170100054A1 · Tai · 2017 [cited by examiner]
US 20180303372A1 · Bozsak et al. · 2018 [cited by applicant]
US 20210174957A1 · Lebedev et al. · 2021 [cited by applicant]
AU 4755602A · 2002 [cited by applicant]
CN 1244779A · 2000 [cited by applicant]
CN 1400462A · 2003 [cited by applicant]
CN 1504578A · 2004 [cited by applicant]
CN 101511292A · 2009 [cited by applicant]
CN 102016575A · 2011 [cited by applicant]
CN 102341039A · 2012 [cited by applicant]
CN 102973267A · 2013 [cited by applicant]
CN 1353619A · 2022 [cited by applicant]
DE 10103503A1 · 2002 [cited by applicant]
EP 0904739A · 1999 [cited by applicant]
EP 2271933B1 · 2012 [cited by applicant]
JP 2003536179A · 2003 [cited by applicant]
JP 2004517677A · 2004 [cited by applicant]
JP 2004520865A · 2004 [cited by applicant]
JP 2011520118A · 2011 [cited by applicant]
JP 2015533611A · 2015 [cited by applicant]
WO WO9942176A1 · 1999 [cited by applicant]
WO WO0137726A1 · 2001 [cited by applicant]
WO WO0232335A1 · 2002 [cited by applicant]
WO WO03057011A2 · 2003 [cited by applicant]
WO WO2006113747A2 · 2006 [cited by applicant]
WO WO2009096821A1 · 2009 [cited by applicant]
WO WO2009103156A1 · 2009 [cited by applicant]
WO WO2009136157A2 · 2009 [cited by applicant]
WO WO2014071223A1 · 2014 [cited by applicant]
WO WO2016011309A2 · 2016 [cited by applicant]
WO 2016055666A1 · 2016 [cited by applicant]
WO WO2016050972A1 · 2016 [cited by applicant]
WO 2016181318A1 · 2016 [cited by applicant]
Amemiya et al., Denkikagaku: Sokutei to Kaiseki no Tebiki Inpidansuhou (1). Electrochemistry, Electrochemistry society of japan. Apr. 5, 2006;74(4):351-357. [cited by applicant]
French Communication for French Application No. 1459531 dated Oct. 3, 2014. [cited by applicant]
French Communication for French Application No. 1459531 dated Jun. 30, 2015. [cited by applicant]
Written Opinion on Patentability for French Application No. 1560174 dated Oct. 23, 2015. [cited by applicant]
Preliminary Search Report for French Application No. 1560174 dated Jun. 17, 2016. [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/EP2015/072859 dated Dec. 3, 2015. [cited by applicant]
International Preliminary Report on Patentability for International Application No. PCT/EP2015/072859 dated Apr. 13, 2017. [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/EP2016/075456 dated Dec. 9, 2016. [cited by applicant]
International Preliminary Report on Patentability for International Application No. PCT/EP2016/075456 dated May 3, 2018. [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/EP2017/058169 dated Jun. 21, 2017. [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/IB2017/001230 dated May 4, 2018. [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/EP2017/079960 dated Apr. 5, 2018. [cited by applicant]
[No Author Listed], Electronique et informatique. Daniel Robert. http://www.electronique-et-informatique.fr/anglais/Digit/Digit_8T.html Sep. 22, 2006. Last accessed Aug. 7, 2018. 9 pages. [cited by applicant]
[No Author Listed], Ring oscillator. https://en.wikipedia.org/w/index.php?title=Ring_oscillator&oldid=674008095 Aug. 1, 2015. Last accessed Aug. 7, 2018. 4 pages. [cited by applicant]
Bilge et al., Label-Free Recognition of Drug Resistance via Impedimetric Screening of Breast Cancer Cells. Plos One. 2013;8(3). [cited by applicant]
Nguyen et al., A cell impedance sensor chip for cancer cells detection with single cell resolution. 2013 IEEE Sensors. Nov. 3, 2013. 1-4. [cited by applicant]
Srinivasaraghavan et al., Microelectrode bioimpedance analysis distinguishes basal and claudin-low subtypes of triple negative breast cancer cells. Biomedical Microdevices. 2015;17(4):1-11. [cited by applicant]
Xu et al., A review of impedance measurements of whole cells. Biosensors and Bioelectronics. Oct. 22, 2015. vol. 77. 824-836. [cited by applicant]
European Communication for European Application No. 16785160.9 dated Sep. 16, 2019. [cited by applicant]
Arndt et al., Bioelectrical impedance assay to monitor changes in cell shape during apoptosis. Biosensors and Bioelectronics. 2004; 19:583-94. [cited by applicant]
Brug et al., The Analysis of Electrode Impedances Complicated by the Presence of a Constant Phase Element. Journal of Electroanalytical Chemistry and Interfacial Electrochemistry. 1984;176:275-95. [cited by applicant]
Chauveau et al., Ex Vivo Discrimination between Normal and Pathological Tissues in Human Breast Surgical Biopsies Using Bioimpedance Spectroscopy. Annals of the New York Academy of Sciences. 1999;873:42-50. [cited by applicant]
Cho et al., Chip-based time-continuous monitoring of toxic effects on stem cell differentiation. Annals of Anatomy. 2009;191:145-52. [cited by applicant]
Cho et al., Electrical characterization of human mesenchymal stem cell growth on microelectrode. Microelectronic Engineering. Science Direct. 2008;85:1272-4. [cited by applicant]
Cho et al., Impedance monitoring of herpes simplex virus-induced cytopathic effect in Vero cells. Elsevier. Sensors and Actuators B. 2007;123:978-82. [cited by applicant]
Cole et al., Dispersion and Absorption in Dielectrics. Journal of Chemical Physics. 1941;9:341-51. [cited by applicant]
Franks et al., Impedance Characterization and Modeling of Electrodes for Biomedical Applications. Biomedical Engineering. IEEE Transactions on Biomedical Engineering. 2005;52(7):1295-1302. [cited by applicant]
Giaever et al., A morphological biosensor for mammalian cells. Nature. 1993;366:591-2. [cited by applicant]
Giaever et al., Micromotion of mammalian cells measured electrically. Proceedings of the National Academy of Sciences. 1991;88:7896-900. [cited by applicant]
Grimnes et al., Bioimpedance and Bioelectricity Basics. Academic. Elsevier. Second Edition. 2000. 484 pages. [cited by applicant]
Qiao et al., Bioimpedance Analysis for the Characterization of Breast Cancer Cells in Suspension. Biomedical Engineering. IEEE Transactions. 2012;59:2321-90. [cited by applicant]
Helen et al., Investigation of tissue bioimpedance using a macro-needle with a potential application in determination of needle-to-nerve proximity. Proceedings of the 8th International Conference on Sensing Technology. … [cited by applicant]
Hilderbrandt et al., Detection of the osteogenic differentiation of mesenchymal stem cells in 2D and 3D cultures by electrochemical impedance spectroscopy. Journal of Biotechnology. 2010;148:83-90. [cited by applicant]
Hirschorn et al., Determination of effective capacitance and film thickness from constant- phase-element parameters. Electrochimica Acta. 2010;55:6218-27. [cited by applicant]
Linderholm et al., Two-dimensional impedance imaging of cell migration and epithelial stratification. Lab on a Chip. Paper. 2006;6:1155-62. [cited by applicant]
Luong et al., Monitoring Motility, Spreading, and Mortality of Adherent Insect Cells Using an Impedance Sensor. Analytical Chemistry. 2001;73:1844-8. [cited by applicant]
Orazem et al., Electrochemical Impedance Spectroscopy. John Wiley & Sons, Inc. 2008. 533 pages. [cited by applicant]
Orazem et al., Dielectric Properties of Materials Showing Constant-Phase-Element (CPE) Impedance Response. Journal of the Electrochemcial Society. 2013; 160(6):C215-C225. [cited by applicant]
Pauly et al., Electrical Properties of Mitochondrial Membranes. The Journal of Biophysical and Biochemical Cytology. 1960;7(4):589-601. [cited by applicant]
Rigaud et al., In vitro tissue characterization and modelling using electrical impedance measurements in the 100 Hz-10 MHz frequency range. Physiological Measurement. 1995;16:A15-A28. [cited by applicant]
Schade-Kampmann et al., On-chip non-invasive and label-free cell discrimination by impedance spectroscopy. Cell Prolif. 2008;41:830.40. [cited by applicant]
Xiao et al., Assessment of Cytotoxicity Using Electric Cell-Substrate Impedance Sensing: Concentration and Time Response Function Approach. Analytical Chemistry. 2002;74:5748-53. [cited by applicant]
Xing, Jinghua, Chinese Search Report in CN Application No. 201780084152.6, mailed Nov. 28, 2022. [cited by applicant]
Wang, Quingyan, et al. Chinese Office Action in CN Application No. 201780084152.6, mailed Dec. 2, 2022 (31 pages). [cited by applicant]
Shimomura, Isseki. Office Action in JP Application No. 2022-187990, mailed Nov. 21, 2023, (18 pages). [cited by applicant]